バイオ医薬品チューブの世界市場レポート 2024年

バイオ医薬品チューブ市場規模は、今後数年で急成長が見込まれます。2028年にはCAGR11.4％で66億5,000万米ドルに成長します。予測期間中に予想される成長は、バイオ医薬品生産の増加、規制政策の厳格化、効率的で汚染のないバイオプロセスへのニーズの高まり、安全対策の強化、医薬品研究開発への投資の増加などに起因すると考えられます。この期間に予想される主な動向としては、シングルユースシステムの発展、チューブ素材の革新、カスタマイズチュービングソリューションの開発、チューブ設計の改善などが挙げられます。

個別化医療の利用拡大がバイオ医薬品チューブ市場の拡大を牽引すると予想されます。個別化医療とは、ヘルスケアの決定、実践、介入、治療を患者一人ひとりの特性に合わせてカスタマイズするアプローチです。このアプローチは、遺伝子研究の進歩により、個人の遺伝子プロファイル、ライフスタイル、特定の健康状態に合わせた治療戦略を可能にし、支持を集めています。バイオ医薬品チューブは、正確で無菌かつ信頼性の高い輸液を確保することで、個別化医療において重要な役割を果たしています。例えば、米国を拠点とする会員組織である個別化医療連合（Personalized Medicine Coalition）は、2022年に、新たに承認された治療法の約34％に相当する12の個別化新薬の承認を報告しました。これは以前に比べて大幅な増加であり、バイオ医薬品チューブ市場の成長を牽引する個別化医療の役割を浮き彫りにしています。

バイオ医薬品チューブ市場の主要企業は、高度なバイオ医薬品アプリケーションの性能、無菌性、流体ハンドリングを強化するため、生体吸収性チューブなどの次世代ソリューションで製品提供を進めています。生体吸収性チューブは、体内で徐々に分解・吸収され、使用後の取り外しが不要になる素材から作られています。例えば、2023年9月、米国を拠点とする先端ポリマーソリューションのプロバイダーであるゼウス社は、生体吸収性血管足場（BRS）用に設計された次世代の生体吸収性製品であるAbsorv XSE指向性チューブを発表しました。この技術革新により、医療機器メーカーは冠動脈疾患の治療以外にもBRSの応用を模索することができ、様々な手技において金属ステントに取って代わる可能性があります。この新しいチューブは、肉厚とサイジングの均一性を向上させ、レーザー切断工程の効率を高め、より使いやすい足場を実現します。

目次

第1章 エグゼクティブサマリー

第2章 市場の特徴

第3章 市場動向と戦略

第4章 マクロ経済シナリオ

• 高インフレが市場に与える影響
• ウクライナ・ロシア戦争が市場に与える影響
• COVID-19による市場への影響

第5章 世界の市場規模と成長

• 世界のバイオ医薬品チューブ市場：促進要因と抑制要因
  • 市場促進要因
  • 市場抑制要因
• 世界のバイオ医薬品チューブ市場の実績：規模と成長, 2018-2023
• 世界のバイオ医薬品チューブ市場の予測：規模と成長, 2023-2028, 2033F

第6章 市場セグメンテーション

• 世界のバイオ医薬品チューブ市場：製品別、実績と予測, 2018-2023, 2023-2028F, 2033F
• シリコンチューブ
• ポリ塩化ビニル（PVC）チューブ
• ポリオレフィンチューブ
• 熱可塑性エラストマーチューブ
• 世界のバイオ医薬品チューブ市場：製造工程別、実績と予測, 2018-2023, 2023-2028F, 2033F
• 押し出し
• 加硫
• その他の製造工程
• 世界のバイオ医薬品チューブ市場：用途別、実績と予測, 2018-2023, 2023-2028F, 2033F
• 製薬
• 医療機器
• 研究開発
• その他の用途

第7章 地域別・国別分析

• 世界のバイオ医薬品チューブ市場：地域別、実績と予測, 2018-2023, 2023-2028F, 2033F
• 世界のバイオ医薬品チューブ市場：国別、実績と予測, 2018-2023, 2023-2028F, 2033F

第8章 アジア太平洋市場

第9章 中国市場

第10章 インド市場

第11章 日本市場

第12章 オーストラリア市場

第13章 インドネシア市場

第14章 韓国市場

第15章 西欧市場

第16章 英国市場

第17章 ドイツ市場

第18章 フランス市場

第19章 イタリア市場

第20章 スペイン市場

第21章 東欧市場

第22章 ロシア市場

第23章 北米市場

第24章 米国市場

第25章 カナダ市場

第26章 南米市場

第27章 ブラジル市場

第28章 中東市場

第29章 アフリカ市場

第30章 競合情勢と企業プロファイル

• バイオ医薬品チューブ市場：競合情勢
• バイオ医薬品チューブ市場：企業プロファイル
  • Compagnie de Saint-Gobain S.A.
  • Thermo Fisher Scientific Inc.
  • Merck KGaA
  • GE HealthCare Technologies Inc.
  • Parker Hannifin Corporation

第31章 その他の大手企業と革新的企業

• DuPont de Nemours Inc.
• Freudenberg Group
• Medline Industries LP
• Avantor Inc.
• Alfa Laval AB
• REHAU Group
• W. L. Gore & Associates Inc.
• Sartorius AG
• Elkem ASA
• Trelleborg AB
• Bio-Rad Laboratories Inc.
• Tekni-Plex Inc.
• Pall Corporation
• Zeus Company Inc.
• Watson-Marlow Ltd.

第32章 競合ベンチマーキング

第33章 競合ダッシュボード

第34章 主要な合併と買収

第35章 将来の見通しと潜在的な分析

第36章 付録

Biopharmaceutical tubing refers to specialized tubing used in the production and handling of biopharmaceutical products. It is engineered to meet rigorous standards for sterility, biocompatibility, and precision to ensure the safe and effective handling of sensitive materials throughout both manufacturing and administration processes.

The main products in the biopharmaceutical tubing market include silicone tubing, polyvinyl chloride (PVC) tubing, polyolefin tubing, and thermoplastic elastomer tubing. Silicone biopharmaceutical tubing is known for its flexibility and high purity, made from silicone rubber and specifically designed for use in the biopharmaceutical industry. Manufacturing processes for these tubes include extrusion and vulcanization, with applications spanning pharmaceuticals, medical devices, research and development, and other areas.

The biopharmaceutical tubing market research report is one of a series of new reports from The Business Research Company that provides biopharmaceutical tubing market statistics, including the biopharmaceutical tubing industry global market size, regional shares, competitors with biopharmaceutical tubing market share, detailed biopharmaceutical tubing market segments, market trends, and opportunities, and any further data you may need to thrive in the biopharmaceutical tubing industry. These biopharmaceutical tubing market research reports deliver a complete perspective of everything you need, with an in-depth analysis of the current and future scenarios of the industry.

The biopharmaceutical tubing market size has grown rapidly in recent years. It will grow from $3.88 billion in 2023 to $4.32 billion in 2024 at a compound annual growth rate (CAGR) of 11.3%. The growth during the historic period can be attributed to an increased demand for minimally invasive procedures, a growing elderly population, a heightened need for ultra-pure and corrosion-resistant systems, and a surge in the demand for diagnostic equipment and drug delivery systems.

The biopharmaceutical tubing market size is expected to see rapid growth in the next few years. It will grow to $6.65 billion in 2028 at a compound annual growth rate (CAGR) of 11.4%. The anticipated growth in the forecast period can be attributed to increasing biopharmaceutical production, stricter regulatory policies, a rising need for efficient and contamination-free bioprocessing, heightened safety measures, and growing investment in pharmaceutical R&D. Key trends expected during this period include advancements in single-use systems, innovations in tubing materials, development of customized tubing solutions, and improvements in tubing design.

The growing use of personalized medicines is expected to drive the expansion of the biopharmaceutical tubing market. Personalized medicine is an approach that customizes healthcare decisions, practices, interventions, and treatments to match the individual characteristics of each patient. This approach is gaining traction due to advancements in genetic research, which allow for treatment strategies tailored to an individual's genetic profile, lifestyle, and specific health conditions. Biopharmaceutical tubing plays a crucial role in personalized medicine by ensuring precise, sterile, and reliable fluid transfer, which is essential for delivering customized treatments and therapies. For instance, in 2022, the Personalized Medicine Coalition, a US-based membership organization, reported the approval of 12 new personalized medicines, representing about 34% of all newly approved therapies. This marks a significant increase compared to previous years, highlighting the role of personalized medicines in driving the growth of the biopharmaceutical tubing market.

Key players in the biopharmaceutical tubing market are advancing their product offerings with next-generation solutions, such as bioabsorbable tubing, to enhance performance, sterility, and fluid handling for advanced biopharmaceutical applications. Bioabsorbable tubing is made from materials that gradually break down and are absorbed by the body, eliminating the need for removal after use. For example, in September 2023, Zeus Company Inc., a US-based provider of advanced polymer solutions, introduced the Absorv XSE-oriented tubing, a next-generation bioabsorbable product designed for bioresorbable vascular scaffolds (BRS). This innovation allows medical device manufacturers to explore BRS applications beyond treating coronary artery disease and potentially replace metallic stents in various procedures. The new tubing offers improved wall thickness and sizing uniformity, enhancing efficiency during laser cutting processes and resulting in more usable scaffolds.

In February 2024, EQT Private Equity, a Sweden-based investment management firm, acquired Zeus Company Inc. for $3.4 billion. This acquisition aims to support Zeus's growth by investing in additional production capacity, research and development, and operational excellence, particularly in medical tubing technology. Zeus Company Inc. is a US-based manufacturer known for precision polymer extrusions and custom tubing.

Major companies operating in the biopharmaceutical tubing market are Compagnie de Saint-Gobain S.A., Thermo Fisher Scientific Inc., Merck KGaA, GE HealthCare Technologies Inc., Parker Hannifin Corporation, DuPont de Nemours Inc., Freudenberg Group, Medline Industries LP, Avantor Inc., Alfa Laval AB, REHAU Group, W. L. Gore & Associates Inc., Sartorius AG, Elkem ASA, Trelleborg AB, Bio-Rad Laboratories Inc., Tekni-Plex Inc., Pall Corporation, Zeus Company Inc., Watson-Marlow Ltd., Raumedic AG, Qosina, Optinova AB, ESI Ultrapure

North America was the largest region in the biopharmaceutical tubing market in 2023. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the biopharmaceutical tubing market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in the biopharmaceutical tubing market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The biopharmaceutical tubing market consists of sales of polytetrafluoroethylene (PTFE) tubing, ethylene-vinyl acetate (EVA) tubing, and rubber tubing. Values in this market are 'factory gate' values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Biopharmaceutical Tubing Global Market Report 2024 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on biopharmaceutical tubing market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

• Gain a truly global perspective with the most comprehensive report available on this market covering 50+ geographies.
• Understand how the market has been affected by the COVID-19 and how it is responding as the impact of the virus abates.
• Assess the Russia - Ukraine war's impact on agriculture, energy and mineral commodity supply and its direct and indirect impact on the market.
• Measure the impact of high global inflation on market growth.
• Create regional and country strategies on the basis of local data and analysis.
• Identify growth segments for investment.
• Outperform competitors using forecast data and the drivers and trends shaping the market.
• Understand customers based on the latest market shares.
• Benchmark performance against key competitors.
• Suitable for supporting your internal and external presentations with reliable high quality data and analysis
• Report will be updated with the latest data and delivered to you within 3-5 working days of order along with an Excel data sheet for easy data extraction and analysis.
• All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for biopharmaceutical tubing ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The biopharmaceutical tubing market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

• The market characteristics section of the report defines and explains the market.
• The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
• The forecasts are made after considering the major factors currently impacting the market. These include:

The impact of sanctions, supply chain disruptions, and altered demand for goods and services due to the Russian Ukraine war, impacting various macro-economic factors and parameters in the Eastern European region and its subsequent effect on global markets.

The impact of higher inflation in many countries and the resulting spike in interest rates.

The continued but declining impact of COVID-19 on supply chains and consumption patterns.

• Market segmentations break down the market into sub markets.
• The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
• The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
• The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

• Markets Covered:1) By Product: Silicone Tubing; Polyvinyl Chloride (PVC) Tubing; Polyolefin Tubing; Thermoplastic Elastomer Tubing
• 2) By Manufacturing Process: Extrusion; Vulcanization; Other Manufacturing Processes
• 3) By Application: Pharmaceutical; Medical Devices; Research And Development; Other Applications
• Companies Mentioned: Compagnie de Saint-Gobain S.A.; Thermo Fisher Scientific Inc.; Merck KGaA; GE HealthCare Technologies Inc.; Parker Hannifin Corporation
• Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
• Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
• Time series: Five years historic and ten years forecast.
• Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
• Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
• Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
• Delivery format: PDF, Word and Excel Data Dashboard.

Table of Contents

1. Executive Summary

2. Biopharmaceutical Tubing Market Characteristics

3. Biopharmaceutical Tubing Market Trends And Strategies

4. Biopharmaceutical Tubing Market - Macro Economic Scenario

• 4.1. Impact Of High Inflation On The Market
• 4.2. Ukraine-Russia War Impact On The Market
• 4.3. COVID-19 Impact On The Market

5. Global Biopharmaceutical Tubing Market Size and Growth

• 5.1. Global Biopharmaceutical Tubing Market Drivers and Restraints
  • 5.1.1. Drivers Of The Market
  • 5.1.2. Restraints Of The Market
• 5.2. Global Biopharmaceutical Tubing Historic Market Size and Growth, 2018 - 2023, Value ($ Billion)
• 5.3. Global Biopharmaceutical Tubing Forecast Market Size and Growth, 2023 - 2028, 2033F, Value ($ Billion)

6. Biopharmaceutical Tubing Market Segmentation

• 6.1. Global Biopharmaceutical Tubing Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• Silicone Tubing
• Polyvinyl Chloride (PVC) Tubing
• Polyolefin Tubing
• Thermoplastic Elastomer Tubing
• 6.2. Global Biopharmaceutical Tubing Market, Segmentation By Manufacturing Process, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• Extrusion
• Vulcanization
• Other Manufacturing Processes
• 6.3. Global Biopharmaceutical Tubing Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• Pharmaceutical
• Medical Devices
• Research And Development
• Other Applications

7. Biopharmaceutical Tubing Market Regional And Country Analysis

• 7.1. Global Biopharmaceutical Tubing Market, Split By Region, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 7.2. Global Biopharmaceutical Tubing Market, Split By Country, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

8. Asia-Pacific Biopharmaceutical Tubing Market

• 8.1. Asia-Pacific Biopharmaceutical Tubing Market Overview
• Region Information, Impact Of COVID-19, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 8.2. Asia-Pacific Biopharmaceutical Tubing Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 8.3. Asia-Pacific Biopharmaceutical Tubing Market, Segmentation By Manufacturing Process, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 8.4. Asia-Pacific Biopharmaceutical Tubing Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

9. China Biopharmaceutical Tubing Market

• 9.1. China Biopharmaceutical Tubing Market Overview
• 9.2. China Biopharmaceutical Tubing Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion
• 9.3. China Biopharmaceutical Tubing Market, Segmentation By Manufacturing Process, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion
• 9.4. China Biopharmaceutical Tubing Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion

10. India Biopharmaceutical Tubing Market

• 10.1. India Biopharmaceutical Tubing Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 10.2. India Biopharmaceutical Tubing Market, Segmentation By Manufacturing Process, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 10.3. India Biopharmaceutical Tubing Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

11. Japan Biopharmaceutical Tubing Market

• 11.1. Japan Biopharmaceutical Tubing Market Overview
• 11.2. Japan Biopharmaceutical Tubing Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 11.3. Japan Biopharmaceutical Tubing Market, Segmentation By Manufacturing Process, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 11.4. Japan Biopharmaceutical Tubing Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

12. Australia Biopharmaceutical Tubing Market

• 12.1. Australia Biopharmaceutical Tubing Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 12.2. Australia Biopharmaceutical Tubing Market, Segmentation By Manufacturing Process, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 12.3. Australia Biopharmaceutical Tubing Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

13. Indonesia Biopharmaceutical Tubing Market

• 13.1. Indonesia Biopharmaceutical Tubing Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 13.2. Indonesia Biopharmaceutical Tubing Market, Segmentation By Manufacturing Process, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 13.3. Indonesia Biopharmaceutical Tubing Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

14. South Korea Biopharmaceutical Tubing Market

• 14.1. South Korea Biopharmaceutical Tubing Market Overview
• 14.2. South Korea Biopharmaceutical Tubing Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 14.3. South Korea Biopharmaceutical Tubing Market, Segmentation By Manufacturing Process, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 14.4. South Korea Biopharmaceutical Tubing Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

15. Western Europe Biopharmaceutical Tubing Market

• 15.1. Western Europe Biopharmaceutical Tubing Market Overview
• 15.2. Western Europe Biopharmaceutical Tubing Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 15.3. Western Europe Biopharmaceutical Tubing Market, Segmentation By Manufacturing Process, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 15.4. Western Europe Biopharmaceutical Tubing Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

16. UK Biopharmaceutical Tubing Market

• 16.1. UK Biopharmaceutical Tubing Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 16.2. UK Biopharmaceutical Tubing Market, Segmentation By Manufacturing Process, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 16.3. UK Biopharmaceutical Tubing Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

17. Germany Biopharmaceutical Tubing Market

• 17.1. Germany Biopharmaceutical Tubing Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 17.2. Germany Biopharmaceutical Tubing Market, Segmentation By Manufacturing Process, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 17.3. Germany Biopharmaceutical Tubing Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

18. France Biopharmaceutical Tubing Market

• 18.1. France Biopharmaceutical Tubing Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 18.2. France Biopharmaceutical Tubing Market, Segmentation By Manufacturing Process, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 18.3. France Biopharmaceutical Tubing Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

19. Italy Biopharmaceutical Tubing Market

• 19.1. Italy Biopharmaceutical Tubing Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 19.2. Italy Biopharmaceutical Tubing Market, Segmentation By Manufacturing Process, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 19.3. Italy Biopharmaceutical Tubing Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

20. Spain Biopharmaceutical Tubing Market

• 20.1. Spain Biopharmaceutical Tubing Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 20.2. Spain Biopharmaceutical Tubing Market, Segmentation By Manufacturing Process, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 20.3. Spain Biopharmaceutical Tubing Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

21. Eastern Europe Biopharmaceutical Tubing Market

• 21.1. Eastern Europe Biopharmaceutical Tubing Market Overview
• 21.2. Eastern Europe Biopharmaceutical Tubing Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 21.3. Eastern Europe Biopharmaceutical Tubing Market, Segmentation By Manufacturing Process, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 21.4. Eastern Europe Biopharmaceutical Tubing Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

22. Russia Biopharmaceutical Tubing Market

• 22.1. Russia Biopharmaceutical Tubing Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 22.2. Russia Biopharmaceutical Tubing Market, Segmentation By Manufacturing Process, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 22.3. Russia Biopharmaceutical Tubing Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

23. North America Biopharmaceutical Tubing Market

• 23.1. North America Biopharmaceutical Tubing Market Overview
• 23.2. North America Biopharmaceutical Tubing Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 23.3. North America Biopharmaceutical Tubing Market, Segmentation By Manufacturing Process, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 23.4. North America Biopharmaceutical Tubing Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

24. USA Biopharmaceutical Tubing Market

• 24.1. USA Biopharmaceutical Tubing Market Overview
• 24.2. USA Biopharmaceutical Tubing Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 24.3. USA Biopharmaceutical Tubing Market, Segmentation By Manufacturing Process, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 24.4. USA Biopharmaceutical Tubing Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

25. Canada Biopharmaceutical Tubing Market

• 25.1. Canada Biopharmaceutical Tubing Market Overview
• 25.2. Canada Biopharmaceutical Tubing Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 25.3. Canada Biopharmaceutical Tubing Market, Segmentation By Manufacturing Process, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 25.4. Canada Biopharmaceutical Tubing Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

26. South America Biopharmaceutical Tubing Market

• 26.1. South America Biopharmaceutical Tubing Market Overview
• 26.2. South America Biopharmaceutical Tubing Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 26.3. South America Biopharmaceutical Tubing Market, Segmentation By Manufacturing Process, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 26.4. South America Biopharmaceutical Tubing Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

27. Brazil Biopharmaceutical Tubing Market

• 27.1. Brazil Biopharmaceutical Tubing Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 27.2. Brazil Biopharmaceutical Tubing Market, Segmentation By Manufacturing Process, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 27.3. Brazil Biopharmaceutical Tubing Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

28. Middle East Biopharmaceutical Tubing Market

• 28.1. Middle East Biopharmaceutical Tubing Market Overview
• 28.2. Middle East Biopharmaceutical Tubing Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 28.3. Middle East Biopharmaceutical Tubing Market, Segmentation By Manufacturing Process, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 28.4. Middle East Biopharmaceutical Tubing Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

29. Africa Biopharmaceutical Tubing Market

• 29.1. Africa Biopharmaceutical Tubing Market Overview
• 29.2. Africa Biopharmaceutical Tubing Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 29.3. Africa Biopharmaceutical Tubing Market, Segmentation By Manufacturing Process, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 29.4. Africa Biopharmaceutical Tubing Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

30. Biopharmaceutical Tubing Market Competitive Landscape And Company Profiles

• 30.1. Biopharmaceutical Tubing Market Competitive Landscape
• 30.2. Biopharmaceutical Tubing Market Company Profiles
  • 30.2.1. Compagnie de Saint-Gobain S.A.
    • 30.2.1.1. Overview
    • 30.2.1.2. Products and Services
    • 30.2.1.3. Strategy
    • 30.2.1.4. Financial Performance
  • 30.2.2. Thermo Fisher Scientific Inc.
    • 30.2.2.1. Overview
    • 30.2.2.2. Products and Services
    • 30.2.2.3. Strategy
    • 30.2.2.4. Financial Performance
  • 30.2.3. Merck KGaA
    • 30.2.3.1. Overview
    • 30.2.3.2. Products and Services
    • 30.2.3.3. Strategy
    • 30.2.3.4. Financial Performance
  • 30.2.4. GE HealthCare Technologies Inc.
    • 30.2.4.1. Overview
    • 30.2.4.2. Products and Services
    • 30.2.4.3. Strategy
    • 30.2.4.4. Financial Performance
  • 30.2.5. Parker Hannifin Corporation
    • 30.2.5.1. Overview
    • 30.2.5.2. Products and Services
    • 30.2.5.3. Strategy
    • 30.2.5.4. Financial Performance

31. Biopharmaceutical Tubing Market Other Major And Innovative Companies

• 31.1. DuPont de Nemours Inc.
• 31.2. Freudenberg Group
• 31.3. Medline Industries LP
• 31.4. Avantor Inc.
• 31.5. Alfa Laval AB
• 31.6. REHAU Group
• 31.7. W. L. Gore & Associates Inc.
• 31.8. Sartorius AG
• 31.9. Elkem ASA
• 31.10. Trelleborg AB
• 31.11. Bio-Rad Laboratories Inc.
• 31.12. Tekni-Plex Inc.
• 31.13. Pall Corporation
• 31.14. Zeus Company Inc.
• 31.15. Watson-Marlow Ltd.

32. Global Biopharmaceutical Tubing Market Competitive Benchmarking

33. Global Biopharmaceutical Tubing Market Competitive Dashboard

34. Key Mergers And Acquisitions In The Biopharmaceutical Tubing Market

35. Biopharmaceutical Tubing Market Future Outlook and Potential Analysis

• 35.1 Biopharmaceutical Tubing Market In 2028 - Countries Offering Most New Opportunities
• 35.2 Biopharmaceutical Tubing Market In 2028 - Segments Offering Most New Opportunities
• 35.3 Biopharmaceutical Tubing Market In 2028 - Growth Strategies
  • 35.3.1 Market Trend Based Strategies
  • 35.3.2 Competitor Strategies

36. Appendix

• 36.1. Abbreviations
• 36.2. Currencies
• 36.3. Historic And Forecast Inflation Rates
• 36.4. Research Inquiries
• 36.5. The Business Research Company
• 36.6. Copyright And Disclaimer